| Literature DB >> 34205997 |
Sevasti-Kiriaki Zervou1, Kimon Moschandreou2, Aikaterina Paraskevopoulou1, Christophoros Christophoridis1, Elpida Grigoriadou3, Triantafyllos Kaloudis1, Theodoros M Triantis1, Vasiliki Tsiaoussi2, Anastasia Hiskia1.
Abstract
Cyanotoxins (CTs) produced by cyanobacteria in surface freshwater are a major threat for public health and aquatic ecosystems. Cyanobacteria can also produce a wide variety of other understudied bioactive metabolites such as oligopeptides microginins (MGs), aeruginosins (AERs), aeruginosamides (AEGs) and anabaenopeptins (APs). This study reports on the co-occurrence of CTs and cyanopeptides (CPs) in Lake Vegoritis, Greece and presents their variant-specific profiles obtained during 3-years of monitoring (2018-2020). Fifteen CTs (cylindrospermopsin (CYN), anatoxin (ATX), nodularin (NOD), and 12 microcystins (MCs)) and ten CPs (3 APs, 4 MGs, 2 AERs and aeruginosamide (AEG A)) were targeted using an extended and validated LC-MS/MS protocol for the simultaneous determination of multi-class CTs and CPs. Results showed the presence of MCs (MC-LR, MC-RR, MC-YR, dmMC-LR, dmMC-RR, MC-HtyR, and MC-HilR) and CYN at concentrations of <1 μg/L, with MC-LR (79%) and CYN (71%) being the most frequently occurring. Anabaenopeptins B (AP B) and F (AP F) were detected in almost all samples and microginin T1 (MG T1) was the most abundant CP, reaching 47.0 μg/L. This is the first report of the co-occurrence of CTs and CPs in Lake Vegoritis, which is used for irrigation, fishing and recreational activities. The findings support the need for further investigations of the occurrence of CTs and the less studied cyanobacterial metabolites in lakes, to promote risk assessment with relevance to human exposure.Entities:
Keywords: LC-MS/MS; Lake Vegoritis; SPE; aeruginosamide; aeruginosins; anabaenopeptins; cyanopeptides; cyanotoxins; cylindrospermopsin; microcystins; microginins
Mesh:
Substances:
Year: 2021 PMID: 34205997 PMCID: PMC8230288 DOI: 10.3390/toxins13060394
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Intracellular and extracellular fractions of microcystins (MCs) and cylindrospermopsin (CYN) per sampling date; MCs at (a) Site 1 and (b) Site 2, and CYN at (c) Site 1 and (d) Site 2.
Figure 2Total concentration (sum of intracellular and extracellular) of cyanotoxins (CTs) and cyanopeptides (CPs) detected per sampling date at (a) Site 1 and (b) Site 2.
Figure 3Occurrence of CTs in Lake Vegoritis at (a) Site 1 and (b) Site 2.
Percentage of samples where cyanotoxins (CTs) and cyanopeptides (CPs) were detected during the monitoring period (2018–2020).
| CTs | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CYN | dm | MC-RR | MC-YR | MC-HtyR | dm | MC-LR | MC-HilR | |||||||||
| % Presence | 71 | 12 | 50 | 24 | 7 | 17 | 79 | 5 | ||||||||
|
| ||||||||||||||||
| AP B | AP F | Osc Y | MG FR1 | MG FR3 | MG T1 | MG T2 | AER 602/K139 | AER 298A | AEG A | |||||||
| % Presence | 100 | 98 | 68 | 27 | 27 | 29 | 29 | 45 | 9 | 23 | ||||||
LC–MS/MS detection parameters of CPs.
| Cyanopeptide | tR (min) | Precursor Ion | Product Ions | Collision | Product Ion Assignment | Ref. |
|---|---|---|---|---|---|---|
| MG FR1 | 18.9 | 728.0 | 100.0 | 40 | MeLeu immonium ion | [ |
| 128.2 Q | 40 | Ahda fragment (C8H18N) | [ | |||
| 384.2 | 40 | [M + H-Tyr-Tyr]+ | [ | |||
| MG FR3 | 15.6 | 728.0 | 128.2 | 40 | Ahda fragment (C8H18N) | [ |
| 233.0 Q | 40 | [Pro-Tyr-CO + H]+ | [ | |||
| 442.0 | 40 | [Pro-Tyr-Tyr + H]+ | [ | |||
| MG T1 | 15.5 | 732.0 | 162.1 | 40 | Cl-Ahda fragment (C8H17NCl) | [ |
| 233.0 Q | 40 | [Pro-Tyr-CO + H]+ | [ | |||
| 442.2 | 40 | [Pro-Tyr-Tyr + H]+ | [ | |||
| MG T2 | 15.7 | 698.0 | 128.2 | 40 | Ahda fragment (C8H18N) | [ |
| 233.0 Q | 40 | [Pro-Tyr-CO + H]+ | [ | |||
| 442.2 | 40 | [Pro-Tyr-Tyr + H]+ | [ | |||
| AER 602/Κ139 | 13.8 | 603.2 | 122.0 | 40 | [Choi immonium-H2O]+ | [ |
| 140.0 | 40 | Choi immonium ion | [ | |||
| 221.2 Q | 40 | Leu-Choi fragment | [ | |||
| AER 298A | 13.6 | 605.3 | 122.0 | 40 | [Choi immonium-H2O]+ | [ |
| 140.0 | 40 | Choi immonium ion | [ | |||
| 311.0 Q | 40 | [Choi-Argininol-NH2 + H]+ | [ | |||
| AEG A | 24.6 | 561.4 | 86.0 | 40 | [PreNH3]+ | This study |
| 112.0 | 40 | TzlCO | [ | |||
| 154.2 Q | 40 | [(Pre)2NH2]+ | This study | |||
| AP B | 14.8 | 837.4 | 84.0 | 40 | Lys immonium ion | [ |
| 201.1 Q | 40 | CO-Arg (side chain) | [ | |||
| 637.3 | 40 | [Lys-Phe-MeAla-HTyr-Val + 2H]+ | [ | |||
| AP F | 15.2 | 851.3 | 84.0 | 40 | Lys immonium ion | [ |
| 201.0 Q | 40 | CO-Arg (side chain) | [ | |||
| 651.4 | 40 | [Lys-Phe-MeAla-HTyr-Ile + 2H]+ | [ | |||
| OSC Y | 19.9 | 858.4 | 84.0 | 40 | Lys immonium ion | [ |
| 405.0 Q | 40 | [M + H-Tyr-(Htyr-Ile)]+ | [ | |||
| 681.4 | 40 | [M + H-Htyr]+ | [ |
quantifier ion.
Figure 4Example of TIC and MRM chromatograms of quantifier transitions for the intracellular fraction of CPs (sample taken on 7 September 2020, Site 1).
Figure 5Structure of proposed fragment ions of AEG A.
Recoveries of target CPs from water (extracellular and intracellular).
| MG FR1 | MG FR3 | MG T1 | MG T2 | AER 602/K139 | AER 298A | AEG A | AP B | AP F | Osc Y | |
|---|---|---|---|---|---|---|---|---|---|---|
| Extracellular | 103.7% | 79.7% | 86.5% | 77.0% | 163.5% | 129.2% | 17.1% | 102.7 | 108.6% | 95.8% |
| Intracellular | 74.0% | 75.5% | 75.1% | 75.6% | 88.8% | 98.3% | 7.5% | 87.2% | 96.5% | 73.4% |
Figure 6Occurrence of CPs detected in Lake Vegoritis at (a) Site 1 and (b) Site 2.
Figure 7Intracellular and extracellular fractions of APs, MGs, AERs and AEG A per sampling date; APs at (a) Site 1 and (b) Site 2; MGs at (c) Site 1 and (d) Site 2; AERs at (e) Site 1 and (f) Site 2; and AEG A at (g) Site 1 and (h) Site 2.
Figure 8The (a) map and (b) sampling points of Lake Vegoritis.